We are live on ! Find out more
WRM

Weybosset Research & Management Portfolio holdings

AUM $381M
1-Year Est. Return 42.16%
This Fund
S&P 500
This Quarter Est. Return
-12.98%
1 Year Est. Return
+42.16%
3 Year Est. Return
+73.45%
5 Year Est. Return
10 Year Est. Return
AUM
$147M
AUM Growth
-$27M
Cap. Flow
-$3.28M
Cap. Flow %
-2.24%
Top 10 Hldgs %
53.68%
Holding
57
New
2
Increased
16
Reduced
29
Closed
5

Top Buys

Rank Stock Value
1
ABBV icon
AbbVie
ABBV
+$413K
2
WELL icon
Welltower
WELL
+$197K
3
COF icon
Capital One
COF
+$71.9K
4
FMC icon
FMC
FMC
+$67.7K
5
NOK icon
Nokia
NOK
+$63.8K

Top Sells

Rank Stock Value
1
INGR icon
Ingredion
INGR
+$930K
2
PII icon
Polaris
PII
+$492K
3
APTV icon
Aptiv
APTV
+$421K
4
SLB icon
SLB Ltd
SLB
+$332K
5
AMZN icon
Amazon
AMZN
+$224K

Sector Composition

Rank Sector Weight
1 Industrials 31.77%
2 Financials 15.79%
3 Technology 12.42%
4 Healthcare 11.06%
5 Consumer Discretionary 10.31%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ATOM icon
51
Atomera
ATOM
$219M
$46K 0.03%
16,100
+2,100
+15% +$8.34K
GE icon
52
GE Aerospace
GE
$391B
-2,843
Closed -$154K
GOOGL icon
53
Alphabet (Google) Class A
GOOGL
$4.62T
-3,580
Closed -$216K
MO icon
54
Altria Group
MO
$114B
-3,384
Closed -$204K
NAT icon
55
Nordic American Tanker
NAT
$1.36B
-17,250
Closed -$36K
SLB icon
56
SLB Ltd
SLB
$75.4B
-5,450
Closed -$332K

Similar funds

Weybosset Research & Management's Q4 2018 Portfolio in Review

As of Q4 2018, Weybosset Research & Management held 57 positions worth $147M, down 16% from $174M the previous quarter. Its ten largest holdings account for 54% of the portfolio.

Weybosset Research & Management's Q4 2018 filing shows 2 new, 16 increased, 29 reduced and 5 closed positions. Its largest new stake was AbbVie: 4,700 shares worth $433K. The largest sale was Ingredion, an estimated $930K.

By sector, the portfolio is most concentrated in Industrials at 32% of assets, up from 31% a quarter earlier, followed by Financials and Technology.

  • Weybosset Research & Management's largest Q4 2018 buy was AbbVie: 4,700 shares worth $433K.
  • Weybosset Research & Management added most to Welltower in Q4 2018, an estimated $197K increase.
  • Weybosset Research & Management's biggest Q4 2018 reduction was Ingredion, cutting an estimated $930K.
  • Weybosset Research & Management fully exited SLB Ltd in Q4 2018, selling an estimated $332K.
  • Weybosset Research & Management's ten largest holdings make up 54% of its $147M portfolio in Q4 2018.
  • Weybosset Research & Management opened 2 new positions and closed 5 in Q4 2018.
  • Weybosset Research & Management's portfolio value fell 16% quarter-over-quarter to $147M.

Based on Weybosset Research & Management's 13F filing for Q4 2018, filed 25 Jan 2019.